Thursday - December 11, 2025
FDA Issues Warning Letter to BioXtek
December 10, 2025
WASHINGTON, Dec. 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to BioXtek LLC from the Office of Compliance and Biologics Quality:

* * *

Recipient: Bruce R. Werber, DPM, Chief Executive Officer and Founder, BioXtek LLC, 316 NE 1st St, Pompano Beach, FL 33060, United States, docw@bioxtek.com

Issuing Office: Office of Compliance and Biologics Quality, United States

WARNING . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products